Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omaveloxolone bioavailability study: capsule vs yogurt
NCT07019064Phase 1Completed
- Sponsor
- Biogen
- Start
- Jun 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of omaveloxolone (2 arms), sponsored by Biogen. Primary endpoints: Maximum Observed Plasma Concentration of Omaveloxolone, Area Under the Concentration-Time Curve From Time Zero to Time of the Last Measurable Concentration of Omaveloxolone and 1 more. Started Jun 2025; status: completed.
02
Drugs
omaveloxolone
Beyond the preview
Go deeper on NCT07019064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07019064.